Maven Securities LTD Forma Therapeutics Holdings, Inc. Transaction History

Maven Securities LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$7.12 - $20.24 $1.42 Million - $4.05 Million	200,000 New	200,000 $39.9 Million
Q2 2021 Aug 16, 2021	SELL	$22.86 - $30.95 $873,252 - $1.18 Million	-38,200 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$24.58 - $42.82 $208,930 - $363,970	8,500 Added 28.62%	38,200 $976,000
Q4 2020 Feb 12, 2021	BUY	$34.9 - $51.08 $1.04 Million - $1.52 Million	29,700 New	29,700 $1.11 Million

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.